Previous 10 |
Placentia, California--(Newsfile Corp. - May 25, 2021) - InVitro International, Inc. (OTC Pink: IVRO) today announced the appointment of Investor Relations Partners (IRP) to provide external investor relations services to InVitro. IRP is an investor relations and public relations firm repre...
InVitro International (IVRO): Q2 GAAP EPS of -$0.003.Revenue of $0.21MPress Release For further details see: InVitro International reports Q2 results
PLACENTIA, CA / ACCESSWIRE / May 11, 2021 / InVitro International (OTC PINK:IVRO) today announced net income of $10,094 for its first six months of fiscal 2021 and a net loss of $57,704 in the 2 nd fiscal quarter of 2021, ending March 31 st , 2021. These YTD results are 86% below our net in...
PLACENTIA, CA / ACCESSWIRE / February 10, 2021 / InVitro International (OTCPINK:IVRO) is pleased to announce net income of $67,663 in its first fiscal quarter of 2021, ending December 31 st , 2020. This represents a 40% increase compared to net income of $48,177 from prior year's first quart...
PLACENTIA, CA / ACCESSWIRE / December 8, 2020 / InVitro International (OTC PINK:IVRO), is pleased to announce revenues of $1,104,816 and net income of $49,894 for our fiscal year ending on September 30 th , 2020 from our audited financial statements. Although global laboratory testing volume...
News, Short Squeeze, Breakout and More Instantly...
Placentia, California--(Newsfile Corp. - May 2, 2024) - Today, InVitro International (OTC Pink: IVRO), announced second quarter FY '24 sales of $210,615, up 5.8% compared to $199,090 for the same period FY '23. Net income in the quarter was $47,674 versus losses of $3,356 in '23. First half FY '2...
Placentia, California--(Newsfile Corp. - February 14, 2024) - Today, InVitro International (OTC Pink: IVRO), the 38-year-old pioneer developer and marketer of globally approved NON-Animal test technologies, announced first Quarter FY '24 sales ending December 31, 2023, of $211,625 up 1.1% vs. the...
Placentia, California--(Newsfile Corp. - November 13, 2023) - Today, InVitro International (OTC Pink: IVRO), the 38-year-old pioneer developer and marketer of globally approved NON-Animal test technologies, announced sales for FY '23 ending September 30, 2023 of $792,629 ( -7% vs FY '22); net inc...